Background Evidence of glucocorticoids on viral clearance delay of COVID-19 patients is
not clear. Methods In this systematic review and meta-analysis, we searched for studies on …

For coronavirus disease 2019 (COVID-19), effective and well-understood treatment options
are still scarce. Since vaccine efficacy is challenged by novel variants, short-lasting …

Background This study explores the risk factors associated with viral shedding time in
elderly Chinese patients infected with severe acute respiratory syndrome coronavirus 2 …

Background Little is known in distinguishing clinical features and outcomes between
coronavirus disease-19 (COVID-19) and influenza (FLU). Materials/methods Retrospective …

Objectives: This retrospective cohort study aims to explore head-to-head clinical outcomes
and complications associated with tocilizumab or baricitinib initiation among hospitalized …

Background Better understanding of the association between characteristics of patients
hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further …

Objectives: This study explored the clinical outcomes and association of prolonged severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding in patients with severe …

Background Remdesivir (REM) has shown potent antiviral activity in vitro and efficacy in
animal models of COVID-19; nevertheless, clinical trials and real-life reports have shown …

Objective To evaluate determinants of prolonged viral RNA shedding in hospitalized
patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron …

Importance The global COVID-19 pandemic does not appear to end in the near future.
Currently, limited data are available on the risk factors for delayed viral clearance in patients …